ZBIO

ProShares UltraPro Short NASDAQ Biotechnology

Delisted

ZBIO was delisted on the 27th of March, 2020.

7 hedge funds and large institutions have $1.67M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
3
Closed
Calls
$149K
Puts
$487K
Net Calls
-$338K
Net Calls Change
-$590K
Name Holding Trade Value Shares
Change
Shares
Change %
VF
1
Virtu Financial
New York
$835K +$691K +25,724 +479%
Jane Street
2
Jane Street
New York
$476K +$313K +11,663 +192%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$319K -$65K -2,419 -17%
Morgan Stanley
4
Morgan Stanley
New York
$14K +$11.6K +446 +480%
CG
5
Cutler Group
California
$10K -$100 -4 -1%
Simplex Trading
6
Simplex Trading
Illinois
$8K +$8K +305 New
UBS Group
7
UBS Group
Switzerland
$3K -$9.68K -387 -76%